Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Illumina, Inc.

Equities

ILMN

US4523271090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
111.1 USD -2.96% Intraday chart for Illumina, Inc. +0.49% -20.23%
May. 15 Daiwa Securities Adjusts Price Target on Illumina to $120 From $133 MT
May. 14 Transcript : Illumina, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 08:30 AM

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Illumina Files Registration Statement for Planned GRAIL Divestiture
I titoli di Wall Street da tenere d'occhio (aggiornamento)
EE.UU. - Valores a seguir en Wall Street (actualizado)
Illumina reaffirms annual revenue forecast over continued sluggish demand
Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours
Illumina, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024
Illumina, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca
The European Commission Approves Illumina's Plan to Divest Grail
Illumina Secures European Commission's Approval for Grail Divestment
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail
EU approves Illumina's plan to divest cancer test maker Grail
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor
Illumina, Inc. Announces Executive Changes
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger
Boost for Illumina as court adviser rejects EU merger powers
EU court should back Illumina's appeal against EU review of Grail deal, court adviser says
Illumina Investor Carl Icahn Withdraws Bid for Board Seat, Continues Legal Battle Over Grail Acquisition
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. News Illumina, Inc.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW